Last edition
News about "Proteon Pharma to develop bacteriophages as a sust"
Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry
Proteon Pharma To Develop Bacteriophages As A Sust | 18/10/2021 | By Darshana | 509
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members